Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Game Pill’s HANGRY™ to Be Showcased with Live Demos at Pixel Power Play during Toronto Games Week
-
Findell Capital Provides Facts in Response to Oportun's Misleading Narrative
-
Stack Athlete Named Official College Recruiting Partner of Massachusetts Youth Soccer Association
-
Global Immigration Partners Named Immigration Law Firm of the Year – USA by Lawyer International Legal 100 Awards 2025
-
nLIGHT, Inc. Appoints Mark Hartman to Board of Directors
-
Bridger Aerospace Shares Insights on Executive Order to Reshape Wildland Firefighting
-
Aptevo Participating in the BIO International Convention
-
StepStone Real Estate Named Investment Consultancy of the Year by IPE Real Estate for Fourth Consecutive Year
-
Abich Financial wins Best of Loudoun for 7th year in a row!
-
Green Fertilizer Made with Air and Plasma: NitroCapt (Sweden) wins $2M Food Planet Prize 2025 for developing low-emission fertilizers
-
NEWBEAUTY LAUNCHES WHITE GLOVE PROGRAM
-
The launch of the international campaign Pay As You Like
-
Gorilla Technology Sets Q1 2025 Conference Call for June 18th, 2025, at 4:30 p.m. ET
-
Izotropic Provides Marketing Update
-
DigiAsia Corp (FAAS) Reports Strong First Half 2024 Financial Results, Achieves 45% Revenue Growth vs First Half of 2023
-
Wella Professionals Named as Official Partner of F1 Academy
-
Wildwood School Appoints Matt Levinson as Newest Head of School
-
Millennium Hotels and Resorts Unveils Rebranding of Millennium Downtown to M Social Hotel New York Downtown
-
PHX Energy Services Corp. Announces Quarterly Dividend
-
Trucept, Inc. Officially Changes Operating Name to Afinida, Inc. for Improved Business Continuity
-
Grace Therapeutics to Participate in the 2025 BIO International Conference
-
Ratio Therapeutics Partners with Macrocyclics for Exclusive Manufacturing and Distribution of its Radiopharmaceutical Chelator Platform
-
THRIVE Enters the Court: Le-Vel Announces Official Partnership with USA Pickleball
-
Groundbreaking Economic Study and Bipartisan Advocacy Unite Stakeholders in Support of America's Everglades
-
Operation HOPE Founder John Hope Bryant and Business Leader Chaitra Dalton-Bryant Honored with Medal of Valor by Auschwitz Jewish Center Foundation
-
Baltimore Expands Use of Evolve™ Rodent Birth Control Following Successful Pilot
-
Sunnova Secures Interim Court Approval for Debtor-in-Possession Financing
-
Nota AI Achieves 100% Accuracy Through Sony IMX500®-Powered Smart Traffic Solution, Demonstrating Global Competitiveness
-
Tree Island Steel Announces Quarterly Dividend
-
As Markets Teeter, EBC’s David Barrett Calls for Caution, Lower Leverage, and Strategic Gold Allocation
-
Cherry Hill Mortgage Investment Corporation Announces Common and Preferred Dividends for the Second Quarter 2025
-
SynergenX Launches New Mobile App to Streamline Hormone Health Management
-
Pursuit Aerospace Announces Completion of Strategic Acquisition to Expand Capabilities
-
Gong cha Names Stray Kids’ Felix as Global Brand Ambassador
-
POTTERY BARN LAUNCHES COLLABORATION WITH FASHION DESIGNER CYNTHIA ROWLEY
-
June 2025 Letter to Shareholders of Nvni Group Limited
-
SharpLink Gaming Acquires 176,271 ETH for $463 Million, Officially Becoming Largest Publicly-Traded ETH Holder
-
Taseko Annual General Meeting Voting Results
-
Co-Founder of MidCap Howard Widra to Retire at the End of 2026
-
180 Degree Capital Corp. Notes Filing of Updated Preliminary Joint Proxy Statement/Prospectus for Proposed Business Combination With Mount Logan Capital Inc.
-
ESGL Shareholders Approve All Proposals for Business Combination with De Tomaso Automobili
-
Bitcoin Depot Adds to Bitcoin Treasury Holdings Amid Continued Market Momentum
-
Processa Pharmaceuticals to Engage Potential Partners and Investors at BIO International Convention 2025
-
Indaptus Therapeutics, Inc. Announces Sale of $2.3 Million in Private Placement of Convertible Notes and Warrants
-
Horizon Aircraft Partners with MT-Propeller for Hybrid eVTOL Propulsion
-
Panavance Therapeutics Announces Promising Misetionamide (GP-2250) Phase 1 Clinical Trial Interim Findings in Pancreatic Cancer at BIO 2025
-
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Medera and Novoheart Presented Breakthroughs in Human mini-Heart Platforms and Gene Therapy at ISSCR 2025
-
Composition of Kalmar Corporation’s Shareholders’ Nomination Board
-
Blue Origin Astronaut J.D. Russell Launches Alpha Funds to Propel Aerospace Innovation
